- Report
- February 2024
- 95 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- October 2023
- 146 Pages
Global
From €3405EUR$3,528USD£2,921GBP
€4006EUR$4,150USD£3,436GBP
- Report
- May 2023
- 132 Pages
Global
From €917EUR$950USD£787GBP
- Report
- February 2024
- 183 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- August 2021
- 246 Pages
Global
From €5953EUR$6,168USD£5,107GBP
- Report
- July 2023
- 140 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- October 2014
- 296 Pages
- Book
- April 2013
- 720 Pages
The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases.
The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases.
Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more